|

Parkinson's Disease Clinical Trials in Long Beach, CA

21 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseasePhase 17 mi
A Study of Buntanetap in Participants With PDPhase 2/314 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 317 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—20 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 220 mi
Terazosin and Parkinson's Disease Extension StudyPhase 220 mi
Terazosin Effect on Cardiac Changes in Early Parkinson's DiseasePhase 220 mi
Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst StimulationN/A20 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 320 mi
Parkinson's Foundation PD GENEration Genetic Registry—20 mi
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)Phase 220 mi
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseasePhase 1/220 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—20 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/320 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—22 mi
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePhase 222 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 222 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 423 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 230 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 330 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 430 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.